足場技術の市場規模、シェア、動向分析レポート：タイプ別、疾患タイプ別（がん、神経内科）、用途別、最終用途別、地域別、セグメント予測、2023年～2030年

足場技術市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の足場技術市場規模は2023年から2030年にかけて13.87％のCAGRで拡大し、2030年には49億2,000万米ドルに達すると予測されています。

3D細胞培養は、病気を引き起こす微小環境因子を効率的に表現するために組織の生体内の生理的状態を模倣するのに効率的であるため、その応用が拡大しています。

さらに、注射可能なハイドロゲル、自己修復ハイドロゲル、ハイブリッドハイドロゲル、刺激応答性ハイドロゲルなど、新規ハイドロゲルタイプの開発に焦点を当てた研究の増加は、今後数年間で新たな収益創出の機会を開くと期待されています。

また、近年の再生医療や組織工学の著しい進歩により、臓器や組織の再建術に3Dバイオプリンティングの採用が増加しています。3Dバイオプリンティング技術は、市場成長にプラスの影響を与える再生医療分野で最も有利な進歩の1つです。

数多くの企業が、組織再生のための新しい3Dバイオプリント個別化足場を開発しています。例えば、2022年6月、3Dシステムズはユナイテッド・セラピューティクス・コーポレーションと新規3Dプリント臓器技術開発のための共同研究を開始しました。同様に、ナノファイバー足場は、その高い表面積対体積比と天然の細胞外マトリックスの繊維状構造を模倣する能力により、人気を集めています。このような足場は、細胞の接着と増殖に適した微小環境を提供するため、その採用が促進され、予測期間中の市場成長が促進されると予想されます。

さらに、COVID-19の流行は足場技術のマーケットにとってプラスの触媒であり続けています。組織工学は、ウイルス学や疫学を理解し、体外モデルシステムを開発し、感染症に対処するための効率的な治療ソリューションを見つけるために広く使用されています。例えば、2021年10月にAdvanced Healthcare Materials Journalに掲載された研究では、適応免疫の発達のための免疫細胞のリクルート部位として生体材料スキャフォールドを採用したCOVID-19ワクチン候補の開発が実証されました。

足場技術市場レポートハイライト

• ハイドロゲル分野が最も支配的なセグメントとして浮上し、2022年には41.69%の最大収益シェアを占めました。ハイドロゲルの作製に使用される微細加工技術の進歩が、同分野の成長を促進すると期待されています。
• 整形外科、筋骨格系、脊椎部門は、世界中で年間行われる筋骨格系の手術件数が増加しているため、2022年に52.98%の最高市場シェアを占めました。
• 北米が足場技術業界を支配し、2022年に40.44%の最大収益シェアを占めました。ヘルスケア支出の増加と最新の足場技術に関する科学的認識の高まりがこの地域市場を牽引しています。
• 幹細胞治療、再生医療、組織工学分野は2022年に66.45%のシェアを占め、市場を独占しました。この成長は、美容整形手術や再建手術、軟部組織腫瘍修復、その他の用途で足場技術の採用が拡大していることに起因しています。
• バイオテクノロジーおよび製薬機関セグメントは、2022年に46.51%の最大収益シェアで市場を独占しました。このセグメントの成長は、組織工学分野におけるこれらの企業による足場技術の広範な応用によるものです。

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
• 市場の定義
  • 情報分析
  • 市場の形成とデータの視覚化
  • データの検証と公開
• 調査の仮定
• 情報調達
  • 1次調査
• 情報またはデータ分析
• 市場の形成と検証
• 市場モデル
• 世界市場：CAGRの計算
• 目的

第2章 エグゼクティブサマリー

• 市場スナップショット
• セグメントのスナップショット
• 競合情勢のスナップショット

第3章 市場変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助的な市場見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 業界分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 タイプ別のビジネス分析

• 足場技術市場：タイプ変動分析
• ハイドロゲル
  • ハイドロゲル市場推計・予測2018年から2030年（100万米ドル）
  • 創傷治癒
  • 3Dバイオプリンティング
  • 免疫調節
• 高分子足場
  • 高分子足場市場推計・予測2018年から2030年（100万米ドル）
• 微細パターン表面マイクロプレート
  • 微細パターン表面マイクロプレート市場推計・予測2018～2030年（100万米ドル）
• ナノファイバーベースの足場
  • ナノファイバーベースの足場市場推計・予測2018年から2030年（100万米ドル）

第5章 疾患別のビジネス分析

• 足場技術市場：疾患タイプの変動分析
• 整形外科、筋骨格系、脊椎
  • 整形外科、筋骨格系、脊椎市場推計・予測 2018年から2030年（100万米ドル）
• がん
  • がん市場推計・予測 2018年から2030年（100万米ドル）
• 皮膚と外皮
  • 皮膚および外皮市場推計・予測2018年から2030年（100万米ドル）
• 歯科
  • 歯科市場推計・予測 2018年から2030年（100万米ドル）
• 心臓病学および血管学
  • 心臓病学および血管市場推計・予測 2018年から2030年（100万米ドル）
• 神経内科
  • 神経内科市場推計・予測2018年から2030年（100万米ドル）
• 泌尿器科
  • 泌尿器科市場推計・予測2018年から2030年（100万米ドル）
• 消化器科、婦人科
  • 消化器科、婦人科市場推計・予測2018～2030年（100万米ドル）
• その他
  • その他の疾患タイプの市場推計・予測2018年から2030年（100万米ドル）

第6章 用途別のビジネス分析

• 足場技術市場：用途の変動分析
• 幹細胞療法、再生医療、組織工学
  • 幹細胞治療、再生医療、組織工学市場推計・予測 2018年から2030年（100万米ドル）
• 創薬
  • 創薬市場推計・予測 2018年から2030年（100万米ドル）
• その他
  • その他の用途市場推計・予測2018年から2030年（100万米ドル）

第7章 最終用途ビジネス分析

• 足場技術市場：最終用途の変動分析
• バイオテクノロジーおよび製薬組織
  • バイオテクノロジーおよび製薬企業の市場推計・予測と2018年から2030年（100万米ドル）
• 調査および研究所
  • 調査および研究機関の市場推計・予測と2018年から2030年（100万米ドル）
• 病院と診断センター
  • 病院および診断センター市場推計・予測2018年から2030年（100万米ドル）
• その他
  • その他の最終用途市場推計・予測 2018年から2030年（100万米ドル）

第8章 地域ビジネス分析

• 地域別の足場技術市場シェア、2022年および2030年
• 北米
  • 北米の足場技術市場、2018年～2030年（100万米ドル）
  • 米国
  • カナダ
• 欧州
  • 欧州の足場技術市場、2018年～2030年（100万米ドル）
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • アジア太平洋の足場技術市場、2018年～2030年（100万米ドル）
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ラテンアメリカの足場技術市場、2018年～2030年（100万米ドル）
  • ブラジル
  • メキシコ
  • アルゼンチン
• MEA
  • MEAの足場技術市場、2018年～2030年（100万米ドル）
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 会社の分類
• 戦略マッピング
• 企業の市場シェア分析、2022年
• 企業プロファイル・一覧表
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson, And Company
  • 3D Biotek LLC
  • Molecular Matrix, Inc.
  • REPROCELL, Inc.
  • Xanofi
  • Tecan Trading AG
  • Matricel Gmbh
  • Pelobiotech
  • Corning Incorporated
  • Akron Biotech
  • 4titude
  • Nuvasive, Inc.
  • Avacta Life Sciences Limited
  • Medtronic
  • Allergan
  • Vericel Corporation

List of Tables

• Table 1 List of secondary sources
• Table 2 Global scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 3 Global scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 4 Global scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 5 Global scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 6 Global scaffold technology market, by region, 2018 - 2030 (USD Million)
• Table 7 North America scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 8 North America scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 9 North America scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 10 North America scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 11 North America scaffold technology market, by country, 2018 - 2030 (USD Million)
• Table 12 U.S. scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 13 U.S. scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 14 U.S. scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 15 U.S. scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 16 Canada scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 17 Canada scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 18 Canada scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 19 Canada scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 20 Europe scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 21 Europe scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 22 Europe scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 23 Europe scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 24 Europe scaffold technology market, by country, 2018 - 2030 (USD Million)
• Table 25 Germany scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 26 Germany scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 27 Germany scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 28 Germany scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 29 UK scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 30 UK scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 31 UK scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 32 UK scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 33 France scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 34 France scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 35 France scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 36 France scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 37 Italy scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 38 Italy scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 39 Italy scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 40 Italy scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 41 Spain scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 42 Spain scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 43 Spain scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 44 Spain scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 45 Denmark scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 46 Denmark scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 47 Denmark scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 48 Denmark scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 49 Sweden scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 50 Sweden scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 51 Sweden scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 52 Sweden scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 53 Norway scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 54 Norway scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 55 Norway scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 56 Norway scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 57 Asia Pacific scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific scaffold technology market, by country, 2018 - 2030 (USD Million)
• Table 62 Japan scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 63 Japan scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 64 Japan scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 65 Japan scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 66 China scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 67 China scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 68 China scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 69 China scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 70 India scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 71 India scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 72 India scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 73 India scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 74 Australia scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 75 Australia scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 76 Australia scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 77 Australia scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 78 Thailand scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 79 Thailand scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 80 Thailand scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 81 Thailand scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 82 South Korea scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 83 South Korea scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 84 South Korea scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 85 South Korea scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 86 Latin America scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 87 Latin America scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 88 Latin America scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 89 Latin America scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 90 Latin America scaffold technology market, by country, 2018 - 2030 (USD Million)
• Table 91 Brazil scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 92 Brazil scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 93 Brazil scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 94 Brazil scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 95 Mexico scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 96 Mexico scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 97 Mexico scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 98 Mexico scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 99 Argentina scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 100 Argentina scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 101 Argentina scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 102 Argentina scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 103 Middle East and Africa scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 104 Middle East and Africa scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 105 Middle East and Africa scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 106 Middle East and Africa scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 107 Middle East and Africa scaffold technology market, by region, 2018 - 2030 (USD Million)
• Table 108 South Africa scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 109 South Africa scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 110 South Africa scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 111 South Africa scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 112 Saudi Arabia scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 116 UAE scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 117 UAE scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 118 UAE scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 119 UAE scaffold technology market, by end-use, 2018 - 2030 (USD Million)
• Table 120 Kuwait scaffold technology market, by type, 2018 - 2030 (USD Million)
• Table 121 Kuwait scaffold technology market, by disease type, 2018 - 2030 (USD Million)
• Table 122 Kuwait scaffold technology market, by application, 2018 - 2030 (USD Million)
• Table 123 Kuwait scaffold technology market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value chain-based sizing & forecasting
• Fig. 6 Market formulation & validation
• Fig. 7 Scaffold technology market segmentation
• Fig. 8 Market snapshot, 2022
• Fig. 9 Market trends & outlook
• Fig. 10 Market driver relevance analysis (current & future impact)
• Fig. 11 Market restraint relevance analysis (current & future impact)
• Fig. 12 PESTEL analysis
• Fig. 13 Porter's five forces analysis
• Fig. 14 Scaffold technology market: Type outlook and key takeaways
• Fig. 15 Scaffold technology market: Type movement analysis
• Fig. 16 Hydrogels market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 17 Wound healing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 18 3D bioprinting market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 Immunomodulation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Polymeric scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Micropatterned surface microplates market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Nanofiber based scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Scaffold technology market: Disease type outlook and key takeaways
• Fig. 24 Scaffold technology market: Disease type movement analysis
• Fig. 25 Orthopedics, musculoskeletal, & spine market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Skin & integumentary market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Dental market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Cardiology & vascular market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Urology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 GI, gynecology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Other disease types market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Scaffold technology market: Application outlook and key takeaways
• Fig. 35 Scaffold technology market: Application movement analysis
• Fig. 36 Stem cell therapy, regenerative medicine, & tissue engineering market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 Drug discovery market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 Other applications market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 Scaffold technology market: End-Use outlook and key takeaways
• Fig. 40 Scaffold technology market: End-Use movement analysis
• Fig. 41 Biotechnology and pharmaceutical organizations market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 42 Research laboratories and institutes market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 Hospitals and diagnostic center market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 44 Other end-uses market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 45 Global scaffold technology market: Regional outlook and key takeaways
• Fig. 46 Global scaffold technology market: Regional movement analysis
• Fig. 47 North America market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 49 Canada market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 50 Europe market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 51 Germany market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 52 UK market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 53 France market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 54 Italy market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 55 Spain market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 56 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 57 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 58 Norway market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 59 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 60 Japan market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 61 China market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 62 India market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 63 Australia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 64 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 65 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 66 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 67 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 68 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 69 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 70 MEA market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 71 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 72 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 73 UAE market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 74 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Scaffold Technology Market Growth & Trends

The global scaffold technology market size is expected to reach USD 4.92 billion by 2030, expanding at 13.87% CAGR from 2023 to 2030, according to a new study by Grand View Research, Inc. The application of 3D cell cultures is growing as they are efficient in mimicking the in-vivo physiological state of tissues for efficient representation of disease-causing microenvironmental factors.

Furthermore, increasing research focusing on the development of novel hydrogel types including injectable hydrogels, self-healing hydrogels, hybrid hydrogels, and stimuli-responsive hydrogels are expected to open new revenue generation opportunities in the coming years.

In addition, the significant advancements in regenerative medicine and tissue engineering in recent years have increased the adoption of 3D bioprinting for organ and tissue reconstruction procedures. The 3D bioprinting technique is one of the most lucrative advancements in the field of regenerative medicine which can positively affect market growth.

Numerous companies are developing new 3D bio-printed personalized scaffolds for tissue regeneration. For instance, in June 2022, 3D Systems entered a collaboration with United Therapeutics Corporation for the development of novel 3D-printed organ technologies. Similarly, nanofiber scaffolds are gaining traction due to their high surface area-to-volume ratio and their ability to mimic the fibrous structure of the natural extracellular matrix. Such scaffolds provide a suitable microenvironment for cell adhesion and proliferation, which is anticipated to boost their adoption and drive market growth during the forecast period.

Moreover, the COVID-19 pandemic remains a positive catalyst for the market for scaffold technology. Tissue engineering is extensively used for understanding virology and epidemiology, developing in-vitro model systems, and finding efficient therapeutic solutions for dealing with infection. For instance, a study published in the Advanced Healthcare Materials Journal in October 2021 demonstrated the development of a COVID-19 vaccine candidate that employs biomaterial scaffolds as recruitment sites for immune cells for the development of adaptive immunity.

Scaffold Technology Market Report Highlights

• The hydrogels segment emerged as the most dominant segment and accounted for the largest revenue share of 41.69% in 2022. Technological advancements in the microfabrication techniques used for the creation of hydrogels are expected to fuel the segment growth
• The orthopedics, musculoskeletal, and spine segment held the highest market share of 52.98% in 2022 due to the increasing number of musculoskeletal procedures performed annually worldwide
• North America dominated the scaffold technology industry and accounted for the largest revenue share of 40.44% in 2022. Rising healthcare expenditure and increasing scientific awareness about the latest scaffold technologies are driving the regional market
• The stem cell therapy, regenerative medicine, and tissue engineering segment dominated the market with a share of 66.45% in 2022. The growth is attributed to the growing adoption of scaffold technology for aesthetic and reconstruction surgeries, soft tissue tumor repair, and other applications
• The biotechnology and pharmaceutical organizations segment dominated the market with the largest revenue share of 46.51% in 2022. The growth in the segment is due to the extensive application of scaffold technology by these organizations in tissue engineering fields

Table of Contents

Chapter 1. Methodology And Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Information Analysis
  • 1.2.2. Market Formulation & Data Visualization
  • 1.2.3. Data Validation & Publishing
• 1.3. Research Assumptions
• 1.4. Information Procurement
  • 1.4.1. Primary Research
• 1.5. Information Or Data Analysis
• 1.6. Market Formulation & Validation
• 1.7. Market Model
• 1.8. Global Market: CAGR Calculation
• 1.9. Objectives
  • 1.9.1. Objective 1:
  • 1.9.2. Objective 2:

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Demand For 3D Cellular Models In Translational Research
    • 3.2.1.2. Increasing Demand For Body Reconstruction Procedures And Tissue Engineering
    • 3.2.1.3. Advancements In Scaffold Technologies
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Introduction Of Scaffold-Free Technology For 3D Cell Culture
    • 3.2.2.2. Lack Of Consistency In Generated Results
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

• 4.1. Scaffold Technology Market: Type Movement Analysis
• 4.2. Hydrogels
  • 4.2.1. Hydrogels Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 4.2.2. Wound Healing
    • 4.2.2.1. Wound Healing Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 4.2.3. 3D Bioprinting
    • 4.2.3.1. 3D Bioprinting Market Estimates And Forecast 2018 To 2030 (USD Million)
  • 4.2.4. Immunomodulation
    • 4.2.4.1. Immunomodulation Market Estimates And Forecast 2018 To 2030 (USD Million)
• 4.3. Polymeric Scaffolds
  • 4.3.1. Polymeric Scaffolds Market Estimates And Forecast 2018 To 2030 (USD Million)
• 4.4. Micropatterned Surface Microplates
  • 4.4.1. Micropatterned Surface Microplates Market Estimates And Forecast 2018 To 2030 (USD Million)
• 4.5. Nanofiber Based Scaffolds
  • 4.5.1. Nanofiber-Based Scaffolds Market Estimates And Forecast 2018 To 2030 (USD Million)

Chapter 5. Disease Type Business Analysis

• 5.1. Scaffold Technology Market: Disease Type Movement Analysis
• 5.2. Orthopedics, Musculoskeletal, & Spine
  • 5.2.1. Orthopedics, Musculoskeletal, & Spine Market Estimates And Forecast 2018 To 2030 (USD Million)
• 5.3. Cancer
  • 5.3.1. Cancer Market Estimates And Forecast 2018 To 2030 (USD Million)
• 5.4. Skin & Integumentary
  • 5.4.1. Skin & Integumentary Market Estimates And Forecast 2018 To 2030 (USD Million)
• 5.5. Dental
  • 5.5.1. Dental Market Estimates And Forecast 2018 To 2030 (USD Million)
• 5.6. Cardiology & Vascular
  • 5.6.1. Cardiology & Vascular Market Estimates And Forecast 2018 To 2030 (USD Million)
• 5.7. Neurology
  • 5.7.1. Neurology Market Estimates And Forecast 2018 To 2030 (USD Million)
• 5.8. Urology
  • 5.8.1. Urology Market Estimates And Forecast 2018 To 2030 (USD Million)
• 5.9. GI, Gynecology
  • 5.9.1. GI, Gynecology Market Estimates And Forecast 2018 To 2030 (USD Million)
• 5.10. Others
  • 5.10.1. Other Disease Type Market Estimates And Forecast 2018 To 2030 (USD Million)

Chapter 6. Application Business Analysis

• 6.1. Scaffold Technology Market: Application Movement Analysis
• 6.2. Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering
  • 6.2.1. Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering Market Estimates And Forecast 2018 To 2030 (USD Million)
• 6.3. Drug Discovery
  • 6.3.1. Drug Discovery Market Estimates And Forecast 2018 To 2030 (USD Million)
• 6.4. Others
  • 6.4.1. Other Applications Market Estimates And Forecast 2018 To 2030 (USD Million)

Chapter 7. End-Use Business Analysis

• 7.1. Scaffold Technology Market: End-Use Movement Analysis
• 7.2. Biotechnology And Pharmaceutical Organizations
  • 7.2.1. Biotechnology And Pharmaceutical Organizations Market Estimates And Forecast 2018 To 2030 (USD Million)
• 7.3. Research Laboratories And Institutes
  • 7.3.1. Research Laboratories And Institutes Market Estimates And Forecast 2018 To 2030 (USD Million)
• 7.4. Hospitals And Diagnostic Centers
  • 7.4.1. Hospitals And Diagnostic Centers Market Estimates And Forecast 2018 To 2030 (USD Million)
• 7.5. Others
  • 7.5.1. Other End-Uses Market Estimates And Forecast 2018 To 2030 (USD Million)

Chapter 8. Regional Business Analysis

• 8.1. Scaffold Technology Market Share By Region, 2022 & 2030
• 8.2. North America
  • 8.2.1. North America Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.2.2. U.S.
    • 8.2.2.1. Key Country Dynamics
    • 8.2.2.2. Target Disease Prevalence
    • 8.2.2.3. Competitive Scenario
    • 8.2.2.4. Regulatory Framework
    • 8.2.2.5. U.S. Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.2.3. Canada
    • 8.2.3.1. Key Country Dynamics
    • 8.2.3.2. Target Disease Prevalence
    • 8.2.3.3. Competitive Scenario
    • 8.2.3.4. Regulatory Framework
    • 8.2.3.5. Canada Scaffold Technology Market, 2018 - 2030 (USD Million)
• 8.3. Europe
  • 8.3.1. Europe Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.3.2. UK
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Target Disease Prevalence
    • 8.3.2.3. Competitive Scenario
    • 8.3.2.4. Regulatory Framework
    • 8.3.2.5. UK Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.3.3. Germany
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Target Disease Prevalence
    • 8.3.3.3. Competitive Scenario
    • 8.3.3.4. Regulatory Framework
    • 8.3.3.5. Germany Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.3.4. France
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Target Disease Prevalence
    • 8.3.4.3. Competitive Scenario
    • 8.3.4.4. Regulatory Framework
    • 8.3.4.5. France Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.3.5. Italy
    • 8.3.5.1. Key Country Dynamics
    • 8.3.5.2. Target Disease Prevalence
    • 8.3.5.3. Competitive Scenario
    • 8.3.5.4. Regulatory Framework
    • 8.3.5.5. Italy Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.3.6. Spain
    • 8.3.6.1. Key Country Dynamics
    • 8.3.6.2. Target Disease Prevalence
    • 8.3.6.3. Competitive Scenario
    • 8.3.6.4. Regulatory Framework
    • 8.3.6.5. Spain Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.3.7. Denmark
    • 8.3.7.1. Key Country Dynamics
    • 8.3.7.2. Target Disease Prevalence
    • 8.3.7.3. Competitive Scenario
    • 8.3.7.4. Regulatory Framework
    • 8.3.7.5. Denmark Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.3.8. Sweden
    • 8.3.8.1. Key Country Dynamics
    • 8.3.8.2. Target Disease Prevalence
    • 8.3.8.3. Competitive Scenario
    • 8.3.8.4. Regulatory Framework
    • 8.3.8.5. Sweden Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.3.9. Norway
    • 8.3.9.1. Key Country Dynamics
    • 8.3.9.2. Target Disease Prevalence
    • 8.3.9.3. Competitive Scenario
    • 8.3.9.4. Regulatory Framework
    • 8.3.9.5. Norway Scaffold Technology Market, 2018 - 2030 (USD Million)
• 8.4. Asia Pacific
  • 8.4.1. Asia Pacific Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.4.2. Japan
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Target Disease Prevalence
    • 8.4.2.3. Competitive Scenario
    • 8.4.2.4. Regulatory Framework
    • 8.4.2.5. Japan Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.4.3. China
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Target Disease Prevalence
    • 8.4.3.3. Competitive Scenario
    • 8.4.3.4. Regulatory Framework
    • 8.4.3.5. China Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.4.4. India
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Target Disease Prevalence
    • 8.4.4.3. Competitive Scenario
    • 8.4.4.4. Regulatory Framework
    • 8.4.4.5. India Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.4.5. Australia
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Target Disease Prevalence
    • 8.4.5.3. Competitive Scenario
    • 8.4.5.4. Regulatory Framework
    • 8.4.5.5. Australia Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.4.6. Thailand
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Target Disease Prevalence
    • 8.4.6.3. Competitive Scenario
    • 8.4.6.4. Regulatory Framework
    • 8.4.6.5. Thailand Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.4.7. South Korea
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Target Disease Prevalence
    • 8.4.7.3. Competitive Scenario
    • 8.4.7.4. Regulatory Framework
    • 8.4.7.5. South Korea Scaffold Technology Market, 2018 - 2030 (USD Million)
• 8.5. Latin America
  • 8.5.1. Latin America Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.5.2. Brazil
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Target Disease Prevalence
    • 8.5.2.3. Competitive Scenario
    • 8.5.2.4. Regulatory Framework
    • 8.5.2.5. Brazil Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.5.3. Mexico
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Target Disease Prevalence
    • 8.5.3.3. Competitive Scenario
    • 8.5.3.4. Regulatory Framework
    • 8.5.3.5. Mexico Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.5.4. Argentina
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Target Disease Prevalence
    • 8.5.4.3. Competitive Scenario
    • 8.5.4.4. Regulatory Framework
    • 8.5.4.5. Argentina Scaffold Technology Market, 2018 - 2030 (USD Million)
• 8.6. MEA
  • 8.6.1. MEA Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.6.2. South Africa
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Target Disease Prevalence
    • 8.6.2.3. Competitive Scenario
    • 8.6.2.4. Regulatory Framework
    • 8.6.2.5. South Africa Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.6.3. Saudi Arabia
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Target Disease Prevalence
    • 8.6.3.3. Competitive Scenario
    • 8.6.3.4. Regulatory Framework
    • 8.6.3.5. Saudi Arabia Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.6.4. UAE
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Target Disease Prevalence
    • 8.6.4.3. Competitive Scenario
    • 8.6.4.4. Regulatory Framework
    • 8.6.4.5. UAE Scaffold Technology Market, 2018 - 2030 (USD Million)
  • 8.6.5. Kuwait
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Target Disease Prevalence
    • 8.6.5.3. Competitive Scenario
    • 8.6.5.4. Regulatory Framework
    • 8.6.5.5. Kuwait Scaffold Technology Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Share Analysis, 2022
• 9.4. Company Profiles/Listing
  • 9.4.1. Merck KGaA
    • 9.4.1.1. Company Overview
    • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. Thermo Fisher Scientific, Inc.
    • 9.4.2.1. Company Overview
    • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. Becton, Dickinson, And Company
    • 9.4.3.1. Company Overview
    • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. 3D Biotek LLC
    • 9.4.4.1. Company Overview
    • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. Molecular Matrix, Inc.
    • 9.4.5.1. Company Overview
    • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. REPROCELL, Inc.
    • 9.4.6.1. Company Overview
    • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. Xanofi
    • 9.4.7.1. Company Overview
    • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. Tecan Trading AG
    • 9.4.8.1. Company Overview
    • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. Matricel Gmbh
    • 9.4.9.1. Company Overview
    • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. Pelobiotech
    • 9.4.10.1. Company Overview
    • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Strategic Initiatives
  • 9.4.11. Corning Incorporated
    • 9.4.11.1. Company Overview
    • 9.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.11.3. Product Benchmarking
    • 9.4.11.4. Strategic Initiatives
  • 9.4.12. Akron Biotech
    • 9.4.12.1. Company Overview
    • 9.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.12.3. Product Benchmarking
    • 9.4.12.4. Strategic Initiatives
  • 9.4.13. 4titude
    • 9.4.13.1. Company Overview
    • 9.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.13.3. Product Benchmarking
    • 9.4.13.4. Strategic Initiatives
  • 9.4.14. Nuvasive, Inc.
    • 9.4.14.1. Company Overview
    • 9.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.14.3. Product Benchmarking
    • 9.4.14.4. Strategic Initiatives
  • 9.4.15. Avacta Life Sciences Limited
    • 9.4.15.1. Company Overview
    • 9.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.15.3. Product Benchmarking
    • 9.4.15.4. Strategic Initiatives
  • 9.4.16. Medtronic
    • 9.4.16.1. Company Overview
    • 9.4.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.16.3. Product Benchmarking
    • 9.4.16.4. Strategic Initiatives
  • 9.4.17. Allergan
    • 9.4.17.1. Company Overview
    • 9.4.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.17.3. Product Benchmarking
    • 9.4.17.4. Strategic Initiatives
  • 9.4.18. Vericel Corporation
    • 9.4.18.1. Company Overview
    • 9.4.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.4.18.3. Product Benchmarking
    • 9.4.18.4. Strategic Initiatives